Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract

Table 3

A table showing liver function test (LFT) before and three (3) months after C.  membranaceus ethanolic root extract administration at 20 mg t.i.d.

Parameter	Mean ± SD (before)	Mean ± SD (after)	value
AST (U/L)	17.8 ± 4.4	18.6 ± 5.1	0.391
ALT (U/L)	16.9 ± 6.5	17.9 ± 5.7	0.465
GGT (U/L)	34.9 ± 15.3	35.8 ± 19.2	0.729
ALP (U/L)	76.6 ± 52.3	68.8 ± 20.6	0.441
TP (g/L)	74.4 ± 6.9	75.3 ± 9.0	0.495
ALB (g/L)	44.2 ± 4.8	46.0 ± 7.2	0.092
TBIL (mol/L)	4.9 ± 2.6	8.3 ± 4.7	0.001
DBIL (mol/L)	2.9 ± 2.2	3.4 ± 2.5	0.347
IND BIL (mol/L)	2.0 ± 1.8	4.8 ± 4.5	0.001

Significance at 95% confidence interval.